Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study on the Safety and Effectiveness of Zilucoplan Auto-Injector for Adults with Generalized Myasthenia Gravis
PolandStudy of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation
FranceStudy on Early Temozolomide Treatment for Adults with Glioblastoma
BelgiumStudy to Evaluate mRNA-3210 for Safety and Tolerability in Patients with Phenylketonuria
FranceStudy of Troriluzole and ADI-PEG-20 for Patients with Newly Diagnosed and Recurrent Glioblastoma
FranceStudy of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months
FranceStudy on the Safety and Effectiveness of LT3001 for Patients with Acute Ischemic Stroke
CzechiaStudy on Long-Term Safety and Effects of PTC518 for Patients with Huntington's Disease
AustriaStudy on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17
BelgiumStudy Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine
AustriaStudy on the Safety and Effects of MBF-015 for Patients with Huntington's Disease
SpainStudy Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues
BulgariaThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
